Thursday, 22 September 2016

Novartis drug Zykadia gets positive trial results

ZURICH (Reuters) - Novartis cancer drug Zykadia showed positive results in a phase III clinical trial in treating patients with a form of lung cancer, the Swiss drugmaker said on Friday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)